Open Journal of Endocrine and Metabolic Diseases

Volume 4, Issue 11 (November 2014)

ISSN Print: 2165-7424   ISSN Online: 2165-7432

Google-based Impact Factor: 1  Citations  h5-index & Ranking

Calcitonin Secretion under Insulin Hypoglycemia

HTML  XML Download Download as PDF (Size: 2531KB)  PP. 231-237  
DOI: 10.4236/ojemd.2014.411023    2,468 Downloads   3,051 Views  Citations


The increasing secretion of calcitonin and hypocalcemia under insulin hypoglycemia, induced with insulin injection (1 IU/100g), was established. Physiological mechanisms of the stimulating effect of insulin hypoglycemia on calcitonin secretion were studied in double-side adrenalectomized and pancreatectomized rats and under the blocking synaptic transmission in sympathetic ganglions or via peripheral cholino- and adreno-receptor structures. Insulin hypoglycemia didn’t expose the increasing secretion of calcitonin in rats under adrenalectomy and pancreatectomy. Ganglion-blocker pentamin (2.5 mg/100g body weight), blocker of M-cholino-receptors atropine (0.2 ml), α-adreno-blocker tropaphen (0.1 mg/100g), and β-adreno-blocker obzidan (0.1 mg/100g) evoked the inhibiting effect on calcitonin secretion in spite of simultaneously increasing of hypog-lycemia. Corticosteroids and, obviously, glucagon and also the tone of autonomic nervous system via peripheral M-cholinoreactive and α- and β-adrenoreactive structures take part in the activation of calcitonin secretion under insulin hypoglycemia.

Share and Cite:

Moisa, S. and Nozdrachev, A. (2014) Calcitonin Secretion under Insulin Hypoglycemia. Open Journal of Endocrine and Metabolic Diseases, 4, 231-237. doi: 10.4236/ojemd.2014.411023.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.